According to a study, while drug companies have begun to develop genetic tests for experimental drugs, many of which have yet to go into clinical trials , common pharmaceuticals already widely prescribed by GPs and hospital doctors are largely being neglected. In Britain alone, an estimated 10,000 people die each year from the side effects of drugs, with tens of thousands more becoming seriously ill.
Guardian Unlimited | The Guardian | Market forces block tailored medicines, says expert
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- ► 2006 (77)
- Wall Street Caves in to Anti-Science Terrorists
- The "Postive" Era of Gentically Modified Foods is...
- China promotes new typing reagent for leukemia
- New kind of health care is coming, says acting FDA...
- Possible Conflicts for Doctors Are Seen on Medical...
- Thomas Tuschl's groundbreaking work in the field o...
- Elan & Biogen plan relaunch of Tysabri
- Gene that controls the severity of asthma identifi...
- Study: Medical Research Spending Jumps
- New Orleans' Health System Faces Crisis
- Market forces block tailored medicines, says exper...
- Scientists Find Genetic Clues in Fanconi Anemia
- Glowing Mice - Jumping Genes
- Exiled from their La. labs, scientists assess thei...
- Super Bug
- Calif.'s Stem Cell Agency Awards Grants
- New Technique Tracks Stem Cells' Progress
- Study holds promise for new way to fight HIV
- Breast Cancer Risk Increased for African Americans...
- ▼ September (19)